The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a grave threat to global public health and imposes a severe burden on the entire human society. Like other coronaviruses, the SARS-CoV-2 genome encodes spike (S)...
Main Authors: | Liangwei Duan, Qianqian Zheng, Hongxia Zhang, Yuna Niu, Yunwei Lou, Hui Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.576622/full |
Similar Items
-
Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
by: Edison Ong, et al.
Published: (2021-01-01) -
The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
by: Michael D. Knierman, et al.
Published: (2020-12-01) -
Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
by: Lin Wang, et al.
Published: (2020-11-01) -
Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein
by: Yue Xing, et al.
Published: (2020-07-01) -
The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV
by: Mayanka Awasthi, et al.
Published: (2020-08-01)